BioAtla - Stock Price History | BCAB

Historical daily share price chart and data for BioAtla since 2021 adjusted for splits. The latest closing stock price for BioAtla as of September 27, 2021 is 31.80.
  • The all-time high BioAtla stock closing price was 70.91 on March 18, 2021.
  • The BioAtla 52-week high stock price is 76.63, which is 141% above the current share price.
  • The BioAtla 52-week low stock price is 27.15, which is 14.6% below the current share price.
  • The average BioAtla stock price for the last 52 weeks is 44.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioAtla Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 33.4309 31.0200 35.1600 31.0200 34.0100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.075B $0.000B
BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29